highly significantP < 0.001
Notably, the NTZ 400 mg/kg group demonstrated a highly significant enhancement in motility ( P < 0.001), emphasizing its therapeutic potential.
Notably, the NTZ 400 mg/kg group demonstrated a highly significant enhancement in motility ( P < 0.001), emphasizing its therapeutic potential.